OXYGEN RADICAL TOXICITY AND RED CELL PROTEIN DEGRADATION

氧自由基毒性和红细胞蛋白降解

基本信息

  • 批准号:
    3447668
  • 负责人:
  • 金额:
    $ 5.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1985
  • 资助国家:
    美国
  • 起止时间:
    1985-02-01 至 1988-01-31
  • 项目状态:
    已结题

项目摘要

It has become apparent in recent years that free radical reactions play an important role in numerous toxicological processes. The long-term goal of this research is to understand the role of free radicals in overall protein turnover, in health and disease. The objective of this application is to test the hypothesis that: "Oxygen radicals damage red cell cytoplasmic proteins, thus increasing the susceptibility of those proteins to degradation by the erythrocyte or reticulocyte proteolytic systems." The specific aims of this proposal are to determine: 1) the structural and functional damage to erythrocyte and reticulocyte cytoplasmic proteins (particularly hemoglobin) induced by various oxygen radicals; 2) the extent to which damage proteins are proteolytically degraded; 3) the functional characteristics of the proteolytic system(s); 4) the effectiveness of cellular free radical defenses. The approach to be employed will involve: 1) protein damage and degradation in intact rabbit-erythrocytes and reticulocytes, as well as cell-free extracts, directly exposed to oxygen radicals; 2) oxygen radical damage to purified hemoglobin, and selected other purified red cell cytoplasmic proteins; 3) degradation of oxygen radical-damaged purified proteins during subsequent incubation with erythrocyte or reticulocyte cell-free extracts. The methodology for protein damage and degradation will include: functional studies, optical spectra, gel electrophoresis, isoelectric focusing, HPLC-gel filtration and DEAE chromatography, amino acid analysis, fluorescamine reactivity, radiolabeling of proteins by reductive methyolation, de novo synthesis of radiolabeled reticulocyte proteins, liquid scintillation of acid-soluble and acid-precipitable radiolabels, antioxidants and radical scavengers, proteolytic inhibitors, oxygen radical generating systems (chemical, enzymatic, and radiolytic). The relationship to health concerns involves: 1) the toxicity of many redox active xenobiotics; 2) the defenses of normal and abnormal cells against oxidative stress; 3) the physiological oxidation and proteolytic degradation of cell proteins.
近年来,自由基反应的作用越来越明显

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kelvin J. A. Davies其他文献

PII: S1567-7249(01)00005-8
PII:S1567-7249(01)00005-8
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Daniela A. Bota;Kelvin J. A. Davies
  • 通讯作者:
    Kelvin J. A. Davies
Skin health and biological aging
皮肤健康与生物衰老
  • DOI:
    10.1038/s43587-025-00901-6
  • 发表时间:
    2025-06-17
  • 期刊:
  • 影响因子:
    19.400
  • 作者:
    David Furman;Johan Auwerx;Anne-Laure Bulteau;George Church;Virginie Couturaud;Laure Crabbe;Kelvin J. A. Davies;Anabelle Decottignies;Vadim N. Gladyshev;Brian K. Kennedy;Nicola Neretti;Carine Nizard;Karl Pays;Daisy Robinton;Vittorio Sebastiano;Rachel E. B. Watson;Meng C. Wang;Knut Woltjen
  • 通讯作者:
    Knut Woltjen

Kelvin J. A. Davies的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kelvin J. A. Davies', 18)}}的其他基金

Research Development Core
研究开发核心
  • 批准号:
    10424590
  • 财政年份:
    2020
  • 资助金额:
    $ 5.8万
  • 项目类别:
Research Development Core
研究开发核心
  • 批准号:
    10261427
  • 财政年份:
    2020
  • 资助金额:
    $ 5.8万
  • 项目类别:
Research Development Core
研究开发核心
  • 批准号:
    10044921
  • 财政年份:
    2020
  • 资助金额:
    $ 5.8万
  • 项目类别:
USC-Buck Geroscience Training Program in the Biology of Aging
南加州大学巴克分校衰老生物学老年科学培训项目
  • 批准号:
    9074506
  • 财政年份:
    2016
  • 资助金额:
    $ 5.8万
  • 项目类别:
OXYGEN RADICAL TOXICITY AND PROTEIN DEGRADATION
氧自由基毒性和蛋白质降解
  • 批准号:
    7910936
  • 财政年份:
    2009
  • 资助金额:
    $ 5.8万
  • 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
  • 批准号:
    6703655
  • 财政年份:
    2000
  • 资助金额:
    $ 5.8万
  • 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
  • 批准号:
    6349732
  • 财政年份:
    2000
  • 资助金额:
    $ 5.8万
  • 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
  • 批准号:
    6071182
  • 财政年份:
    2000
  • 资助金额:
    $ 5.8万
  • 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
  • 批准号:
    6497189
  • 财政年份:
    2000
  • 资助金额:
    $ 5.8万
  • 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
  • 批准号:
    6627931
  • 财政年份:
    2000
  • 资助金额:
    $ 5.8万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 5.8万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 5.8万
  • 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 5.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了